Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Identificação de Variáveis Cinemáticas Específicas da Tendinopatia Patelar em Atletas em Risco (TENVOL)

16 de setembro de 2026 atualizado por: University Hospital, Montpellier

This research aims to identify and monitor specific kinematic markers associated with patellar tendinopathy in athletes at risk. Using a markerless motion capture system, vertical jump tests will be analyzed to detect early biomechanical changes in the knees, hips, trunk, and ankles. By comparing injured participants, the study seeks to improve early diagnosis and personalized prevention strategies for patellar tendinopathy.

Visão geral do estudo

Descrição detalhada

Patellar tendinopathy, also known as Jumper's knee, is the most common pathology in elite sports, with 30% of diagnoses occurring in volleyball. Among elite volleyball players, the prevalence of this overuse-related condition ranges between 40% and 50%, resulting in anterior knee pain during daily and recreational activities, which can lead to deficits in strength and sports performance. To date, investigator can determine whether a patient has had a history of tendinopathy through modifications in biomechanical jump-landing strategies. However, there is a lack of early biomechanical markers to identify the onset of patellar tendinopathy and thus prevent its chronic progression. A preventive strategy using markerless motion capture technology, providing quantitative and visual feedback of a 3D human body model, shows promise. Investigators hypothesize that jump-landing kinematic analysis using markerless technology could identify early kinematic markers specific to patellar tendinopathy, distinguishing affected individuals from a non-tendinopathy population. This could ultimately help identify motor strategies following the onset of patellar tendinopathy A prospective longitudinal multicenter cohort. After signing the consent form, participants will undergo a medical examination, including a clinical assessment, a SLDS test, a Doppler ultrasound of the patellar tendon, and evaluation using the VISA-PF and OSTRC-P scores. Following a standardized 10-minute warm-up, participants will perform vertical jump tests captured by high-resolution cameras, analyzed using markerless motion capture technology. These assessments will be conducted at inclusion and at 3, 6, 9, and 12 months. Additional medical visits will occur if symptoms arise outside of testing.

Tipo de estudo

Intervencional

Inscrição (Estimado)

60

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Locais de estudo

      • Montpellier, França
        • Recrutamento
        • Sports Medicine and Traumatology LAPEYRONIE Hospital - Montpellier University Hospital
        • Contato:

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos a 45 anos (Adulto)

Aceita Voluntários Saudáveis

Sim

Gêneros Elegíveis para o Estudo

Macho

Descrição

  • Subject aged between 18 and 45 years
  • Male subject
  • Regularly participating in physical activity involving jumping (a predisposing factor for patellar tendinopathy) twice a week for at least one year.
  • Participants affiliated with or covered by a social security scheme

SPECIFIC INCLUSION CRITERIA FOR THE PATELLAR TENDINOPATHY GROUP

Patients with at least 2 of the following 3 criteria:

  • Modified Öhberg score ≥2 according to L Öhberg, H Alfredson (2002)
  • VISA-PF < 80/100 according to Kaux et al. (2016) and/or OSTRC P ≥ 6/100 according to Owoeye et al. (2018)
  • Single Leg Decline Squat (SLDS): VAS ≥ 1/10 with pain mapping at the patellar tendon; according to Coombes et al. (2020)

SPECIFIC INCLUSION CRITERIA FOR THE HEALTHY GROUP

Patients with 0 or 1 of the following 3 criteria:

  • Modified Öhberg score ≥2 according to L Öhberg, H Alfredson (2002)
  • VISA-PF < 80/100 according to Kaux et al. (2016) and/or OSTRC P ≥ 6/100 according to Owoeye et al. (2018)
  • Single Leg Decline Squat (SLDS): VAS ≥ 1/10 with pain mapping at the patellar tendon; according to Coombes et al. (2020)

Non inclusion Criteria:

  • Significant medical and surgical history involving the lower limbs (e.g., ACL ligament reconstruction, meniscectomy, etc.)
  • Contraindications to participating in sports activities
  • Other pathologies involving the lower limbs (< 6 months), e.g., torn knee ligaments, ankle sprain, knee sprain, etc.
  • Participants who have not given their informed consent
  • Participants subject to legal protection measures (legal guardianship, conservatorship, curatorship)
  • Participants deprived of their liberty by judicial or administrative decision

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Prevenção
  • Alocação: Não randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: patellar tendinopathy group

Diagnostic Test: The intervention consists of a series of vertical jump tests captured using high-resolution cameras with markerless motion capture technology.

Participants will undergo clinical evaluations including the Single Leg Decline Squat (SLDS) test, VISA-PF, OSTRC-P questionnaires, and Doppler ultrasound of the patellar tendon. These assessments will take place at baseline (T0) and follow-up periods (M3, M6, M9, M12) to track the evolution of kinematic markers and clinical symptoms related to patellar tendinopathy.

Outro: healthy group

Diagnostic Test: The intervention consists of a series of vertical jump tests captured using high-resolution cameras with markerless motion capture technology.

Participants will undergo clinical evaluations including the Single Leg Decline Squat (SLDS) test, VISA-PF, OSTRC-P questionnaires, and Doppler ultrasound of the patellar tendon. These assessments will take place at baseline (T0) and follow-up periods ( M6 et M12) to track the evolution of kinematic markers and clinical symptoms related to patellar tendinopathy.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Variations of knee flexion angle at initial contact at 3 months (only for patients in the patellar tendinopathy group)
Prazo: Between the initial visit and the 3-month visit

The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

Between the initial visit and the 3-month visit
Variations of knee flexion angle at initial contact at 6 months
Prazo: Between the 3-month visit and the 6-month visit

The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

Between the 3-month visit and the 6-month visit
Variations of knee flexion angle at initial contact at 9 months (only for patients in the patellar tendinopathy group)
Prazo: Between the 6-month visit and the 9-month visit

The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

Between the 6-month visit and the 9-month visit
Variations of knee flexion angle at initial contact at 12 months
Prazo: Between the 9-month visit and the 12-month visit

The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

Between the 9-month visit and the 12-month visit
Variations of the maximum knee flexion angle at 3 months (only for patients in the patellar tendinopathy group)
Prazo: Between the initial visit and the 3-month visit

The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

Between the initial visit and the 3-month visit
Variations of the maximum knee flexion angle at 6 months
Prazo: Between the 3-month visit and the 6-month visit

The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

Between the 3-month visit and the 6-month visit
Variations of the maximum knee flexion angle at 9 months (only for patients in the patellar tendinopathy group)
Prazo: Between the 6-month visit and the 9-month visit

The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

Between the 6-month visit and the 9-month visit
Variations of the maximum knee flexion angle at 12 months
Prazo: Between the 9-month visit and the 12-month visit

The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

Between the 9-month visit and the 12-month visit
Variations of the range of motion (ROM) of the knee between initial contact and maximum flexion angle at 3 months (only for patients in the patellar tendinopathy group)
Prazo: Between the initial visit and the 3-month visit

The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

Between the initial visit and the 3-month visit
Variations of the range of motion (ROM) of the knee between initial contact and maximum flexion angle at 6 months
Prazo: Between the 3-month visit and the 6-month visit

The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

Between the 3-month visit and the 6-month visit
Variations of the range of motion (ROM) of the knee between initial contact and maximum flexion angle at 9 months (only for patients in the patellar tendinopathy group)
Prazo: Between the 6-month visit and the 9-month visit

The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

Between the 6-month visit and the 9-month visit
Variations of the range of motion (ROM) of the knee between initial contact and maximum flexion angle at 12 months
Prazo: Between the 9-month visit and the 12-month visit

The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

Between the 9-month visit and the 12-month visit
Variations of the angle at the peak of the vertical ground reaction force (VGRF) at 3 months (only for patients in the patellar tendinopathy group)
Prazo: Between the initial visit and the 3-month visit

The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

Between the initial visit and the 3-month visit
Variations of the angle at the peak of the vertical ground reaction force (VGRF)at 6 months
Prazo: Between the 3-month visit and the 6-month visit

The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

Between the 3-month visit and the 6-month visit
Variations of the angle at the peak of the vertical ground reaction force (VGRF) at 9 months (only for patients in the patellar tendinopathy group)
Prazo: Between the 6-month visit and the 9-month visit

The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

Between the 6-month visit and the 9-month visit
Variations of the angle at the peak of the vertical ground reaction force (VGRF) at 12 months
Prazo: Between the 9-month visit and the 12-month visit

The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

Between the 9-month visit and the 12-month visit
Comparison of variation between healthy group and patellar tendinopathy group of knee flexion angle at initial contact at 6 months
Prazo: Between the two 6-month visits of the two groups

The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

Between the two 6-month visits of the two groups
Comparison between the healthy group and the patellar tendinopathy group of variation of the maximum knee flexion angle at 6 months
Prazo: Between the two 6-month visits of the two groups

The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

Between the two 6-month visits of the two groups
Comparison between the healthy group and the patellar tendinopathy group of variations of the range of motion (ROM) of the knee between initial contact and maximum flexion angle at 6 months
Prazo: Between the two 6-month visits of the two groups

The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

Between the two 6-month visits of the two groups
Comparison between the healthy group and the patellar tendinopathy group of variations of the angle at the peak of the vertical ground reaction force (VGRF)at 6 months
Prazo: Between the two 6-month visits of the two groups

The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

Between the two 6-month visits of the two groups

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Variations of the angle of flexion of the trunk, hips, knees, and ankles at initial contact at 3 months (only for patients in the patellar tendinopathy group)
Prazo: Between the initial visit and the 3-month visit

The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

Between the initial visit and the 3-month visit
Variations of the angle of flexion of the trunk, hips, knees, and ankles at initial contact at 6 months
Prazo: Between the 3-month visit and the 6-month visit

The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

Between the 3-month visit and the 6-month visit
Variations of the angle of flexion of the trunk, hips, knees, and ankles at initial contact at 9 months (only for patients in the patellar tendinopathy group)
Prazo: Between the 6-month visit and the 9-month visit

The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

Between the 6-month visit and the 9-month visit
Variations of the angle of flexion of the trunk, hips, knees, and ankles at initial contact at 12 months
Prazo: Between the 9-month visit and the 12-month visit

The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

Between the 9-month visit and the 12-month visit
Variations of the maximum flexion angle of the trunk, hips, knees, and ankles upon landing at 3 months (only for patients in the patellar tendinopathy group)
Prazo: Between the initial visit and the 3-month visit

The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

Between the initial visit and the 3-month visit
Variations of the maximum flexion angle of the trunk, hips, knees, and ankles upon landing at 6 months
Prazo: Between the 3-month visit and the 6-month visit

The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

Between the 3-month visit and the 6-month visit
Variations of the maximum flexion angle of the trunk, hips, knees, and ankles upon landing at 9 months (only for patients in the patellar tendinopathy group)
Prazo: Between the 6-month visit and the 9-month visit

The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

Between the 6-month visit and the 9-month visit
Variations of the maximum flexion angle of the trunk, hips, knees, and ankles upon landing at 12 months
Prazo: Between the 9-month visit and the 12-month visit

The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

Between the 9-month visit and the 12-month visit
Variations of the range of motion (ROM) of the trunk, hips, knees, and ankles between initial contact and maximum flexion angle upon landing at 3 months (only for patients in the patellar tendinopathy group)
Prazo: Between the initial visit and the 3-month visit

The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

Between the initial visit and the 3-month visit
Variations of the range of motion (ROM) of the trunk, hips, knees, and ankles between initial contact and maximum flexion angle upon landing at 6 months
Prazo: Between the 3-month visit and the 6-month visit

The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

Between the 3-month visit and the 6-month visit
Variations of the range of motion (ROM) of the trunk, hips, knees, and ankles between initial contact and maximum flexion angle upon landing at 9 months (only for patients in the patellar tendinopathy group)
Prazo: Between the 6-month visit and the 9-month visit

The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

Between the 6-month visit and the 9-month visit
Variations of the range of motion (ROM) of the trunk, hips, knees, and ankles between initial contact and maximum flexion angle upon landing at 12 months
Prazo: Between the 9-month visit and the 12-month visit

The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

Between the 9-month visit and the 12-month visit
Variations of the angle at the peak of the vertical ground reaction force (VGRF) of the hips, knees, and ankles upon landing at 3 months (only for patients in the patellar tendinopathy group)
Prazo: Between the initial visit and the 3-month visit

The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

Between the initial visit and the 3-month visit
Variations of the angle at the peak of the vertical ground reaction force (VGRF) of the hips, knees, and ankles upon landing at 6 months
Prazo: Between the 3-month visit and the 6-month visit

The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

Between the 3-month visit and the 6-month visit
Variations of the angle at the peak of the vertical ground reaction force (VGRF) of the hips, knees, and ankles upon landing at 9 months (only for patients in the patellar tendinopathy group)
Prazo: Between the 6-month visit and the 9-month visit

The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

Between the 6-month visit and the 9-month visit
Variations of the angle at the peak of the vertical ground reaction force (VGRF) of the hips, knees, and ankles upon landing at 12 months
Prazo: Between the 9-month visit and the 12-month visit

The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.

Between the 9-month visit and the 12-month visit

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

15 de setembro de 2026

Conclusão Primária (Estimado)

1 de maio de 2029

Conclusão do estudo (Estimado)

1 de maio de 2029

Datas de inscrição no estudo

Enviado pela primeira vez

5 de fevereiro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

5 de fevereiro de 2026

Primeira postagem (Real)

12 de fevereiro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

21 de setembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

16 de setembro de 2026

Última verificação

1 de fevereiro de 2026

Mais Informações

Termos relacionados a este estudo

Termos MeSH relevantes adicionais

Outros números de identificação do estudo

  • RECHMPL25_0117
  • 2025-A01948-41 (Identificador de registro: IdRCB)

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

INDECISO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever